首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >Inhibition of airway remodeling and inflammation by isoforskolin in PDGF-induced rat ASMCs and OVA-induced rat asthma model
【24h】

Inhibition of airway remodeling and inflammation by isoforskolin in PDGF-induced rat ASMCs and OVA-induced rat asthma model

机译:在PDGF诱导的大鼠Asmcs和OVA诱导的大鼠哮喘模型中抑制isoforskolin的气道重塑和炎症

获取原文
获取原文并翻译 | 示例
           

摘要

Highlights ? Isoforskolin had significant antitussive and expectorant effects in mouse models. ? Isoforskolin suppressed the infiltration of inflammatory cells. ? Isoforskolin reversed the mucus oversecretion and collagen overdeposition. Abstract Isoforskolin (ISOF) has been reported to play an important role in many illnesses including respiratory, cardiovascular and ophthalmologic diseases. In our study, we aimed to investigate how ISOF regulates airway remodeling and inflammation in asthma. Based on SO 2 -stimulated mouse cough model, we assessed the role of ISOF in cough and secretion of phlegm. Afterwards, platelet derived growth factor (PDGF)-induced primary rat airway smooth muscle cell (ASMC) model and ovalbumin (OVA)-induced rat asthma model were used to continue our following research. Our results showed that ISOF could prolong the cough latent period, reduce the cough times in two minutes, and increase the excretion of red phenol, which suggested the antitussive and expectorant effects of ISOF. Besides, ISOF pretreatment reversed the hypotonicity and cytoskeleton remodeling in PDGF-induced ASMCs, and reduced mucus hypersecretion and collagen overdeposition in OVA-induced rat asthma model, which indicated its inhibition on airway remodeling in vitro and in vivo . Moreover, ISOF reduced the invasion of inflammatory cells into bronchoalveolar lavage fluid (BALF) and lungs, which revealed its inhibitory role in airway inflammation. The down-regulation of transforming growth factor β1 (TGF-β1) and interleukin-1β (IL-1β) upon ISOF treatment might be responsible for its anti-remodeling and anti-inflammation roles. In conclusion, ISOF can reduce cough and sputum, as well as inhibit airway remodeling and inflammation by regulating the expression of TGF-β1 and IL-1β. These data indicate the potency of ISOF in treating asthma and also provide insights into the development of new anti-asthma agent. ]]>
机译:强调 ? isoforskolin在小鼠模型中具有显着的抗痉挛和祛痰作用。还Isoforskolin抑制了炎症细胞的渗透。还Isoforskolin逆转了粘液的过分分解和胶原蛋白夸张。据报道,摘要isoforskolin(ISOF)在许多疾病中发挥着重要作用,包括呼吸道,心血管和眼科疾病。在我们的研究中,我们旨在调查如何调节哮喘中的气道重塑和炎症。基于SO 2刺激的小鼠咳嗽模型,我们评估了ISOF在咳嗽和分泌痰的作用。然后,血小板衍生的生长因子(PDGF)诱导的原大鼠气道平滑肌细胞(ASMC)模型和卵磷蛋白(OVA)诱导的大鼠哮喘模型用于继续我们的研究。我们的研究结果表明,ISOF可以延长咳嗽潜伏期,在两分钟内减少咳嗽时间,并增加红苯酚的排泄,这提出了ISOF的抗痉挛和祛痰作用。此外,ISOF预处理在PDGF诱导的ASMC中反转了低音和细胞骨架重塑,并降低了OVA诱导的大鼠哮喘模型中的粘液过度折叠和胶原蛋白常存,这表明其对体外和体内气道重塑的抑制作用。此外,ISOO将炎性细胞的侵袭降至支气管肺泡灌洗液(BALF)和肺部,这在气道炎症中揭示了其抑制作用。转化生长因子β1(TGF-β1)和白细胞介素-1β(IL-1β)的下调可能是其抗重塑和抗炎作用的原因。总之,通过调节TGF-β1和IL-1β的表达,ISOO可以减少咳嗽和痰液,以及抑制气道重塑和炎症。这些数据表明ISOF在治疗哮喘的效力,并提供了新的抗哮喘药物的开发的见解。 ]]>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号